Medical Devices

By: Carsl Consulting  06-Dec-2011
Keywords: Medical Devices, Therapeutic Products

Currently medical devices are required to be listed in Medsafe's WAND database within 30 days of being supplied in New Zealand or exported.  The regulatory controls on medical devices were expected to increase significantly on commencement of the Australia New Zealand Therapeutic Products Authority (ANZTPA).  However, there is now uncertainty regarding the future of ANZTPA.  It is expected that Medsafe will therefore introduce further regulatory controls on the distribution of medical devices.  We take every opportunity to provide input into proposed regulations and guidelines for medical devices and can provide advice on the regulatory controls as they become apparent.  We can provide:

  • WAND and DEAL notifications
  • Advice on best approach to transitioning devices to any new regulatory scheme
  • NZ manufacturers of medical devices who wish to enter the larger markets of Australia, Canada and the European countries will require their products to be CE marked.  CARSL Consulting can assist with:
      • ISO 13485 preparation and implementation
      • Conformity Assessment and CE marking
      • Technical file development
      • Registration in Australia and Europe

We also have expertise to assist medical device manufacturers with:

  • Sterilisation
  • Clean Rooms
  • GMP and SOP's
  • Quality and Operational Manuals

Keywords: Medical Devices, Therapeutic Products

Contact Carsl Consulting

Email

Print this page

Other products and services from Carsl Consulting

06-Dec-2011

Regulatory services for Prescription and Non Prescription Medicines

Medicines with approval that undergo material changes may also require Medsafe approval through a Changed Medicine Notification before these changes can take effect. Both Prescription and Non-prescription medicines require approval by Medsafe before they can be distributed in New Zealand. Advice and co-ordination for product development or product sourcing. Changed Medicine Notification preparation, submission and follow-up.


06-Dec-2011

Complementary Medicines

We take every opportunity to provide input into proposed regulations and guidelines for complementary medicines and products at the food/medicine interface and can provide advice concerning forthcoming regulatory requirements. While we support the regulation of complementary medicines in New Zealand, we recognise that such regulation should take into account the nature of the product and of inherent risks involved in their use.


06-Dec-2011

In-Vitro Diagnostics

There is now uncertainty regarding the future of ANZTPA but it is expected that in-vitro diagnostics will eventually come under some regulatory controls in the future. Under the proposed Australia New Zealand Therapeutic Products Authority in-vitro diagnostics would be controlled in a similar fashion to medical devices. We can provide advice on the regulatory controls as they become apparent to ensure compliance for your in-vitro diagnostics.


06-Dec-2011

Pfizer Chemicals

We also supply full technical support for ingredients supplied in New Zealand and can handle any regulatory aspects involved with their use. CARSL Consulting is the New Zealand agent for the Pfizer Centre Source range of pharmaceutical active ingredients. These include corticosteroids, hormones and antimicrobials.